Holen Sie sich die Stockscreener-App
3.01
1.01%
0.03
Handel nachbörslich:
3.02
0.01
+0.33%
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
OraSure (OSUR) CEO gets major stock awards, shares withheld for taxes - Stock Titan
OraSure Technologies, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:OSUR) 2026-03-03 - Seeking Alpha
Healthy Trucking Association Launches Hepatitis C Initiative - Heavy Duty Trucking
OSUR Should I Buy - Intellectia AI
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OraSure Technologies (OSUR) Loss Worsens To US$0.27 EPS And Tests Margin Recovery Narrative - Sahm
OraSure Technologies Q4 Earnings Call Highlights - MarketBeat
OraSure Technologies Inc (OSUR) Q4 2025 Earnings Call Highlights - GuruFocus
OraSure signals revenue ramp in H2 2026 with two FDA-submitted diagnostics launches - MSN
Earnings Call Summary | OraSure Technologies(OSUR.US) Q4 2025 Earnings Conference - 富途牛牛
OraSure: Fourth Quarter Financial Results Overview - Bitget
OraSure Technologies Inc reports results for the quarter ended September 30Earnings Summary - TradingView
OraSure closes the book on 'transition year' of 2025 - WFMZ.com
OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Earnings call transcript: OraSure Technologies Q4 2025 earnings fall short of revenue expectations - Investing.com
OraSure: Q4 Earnings Snapshot - Barchart.com
OraSure Technologies (OSUR) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
OraSure Highlights 2025 Results and 2026 Growth Outlook - TipRanks
OraSure Announces Fourth Quarter 2025 Financial Results - The Manila Times
Revenue drops as OraSure (NASDAQ: OSUR) posts deeper 2025 loss - Stock Titan
Tranche Update on OraSure Technologies, Inc.'s Equity Buyback Plan announced on March 24, 2025. - marketscreener.com
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies (OSUR) Expected to Announce Earnings on Wednesday - MarketBeat
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com Nigeria
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
How sensitive is OraSure Technologies Inc. to inflationJuly 2025 Setups & Verified Chart Pattern Signals - mfd.ru
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test approved for sale in Canada - CBC
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
Orasure to Launch Oraquick?? Hiv Self-Test in Canada - marketscreener.com
OraSure’s HIV self-test receives Health Canada license - Investing.com
OraSure to Launch OraQuick™ HIV Self-Test in Canada - ChartMill
At-home oral HIV self-test approved for sale in Canada - Toronto Sun
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Aug Rallies: Should I set a stop loss on PATH2025 Risk Factors & Long Hold Capital Preservation Tips - baoquankhu1.vn
Does OraSure Technologies Inc. have a sustainable dividendEarnings Growth Summary & Long-Term Capital Growth Strategies - mfd.ru
Investment Review: Can OraSure Technologies Inc maintain sales growth2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Altai Capital nominates two directors to OraSure's board - MSN
The Truth About OraSure Technologies: Is This ‘Boring’ Test Maker Your Next Viral Money Play? - AD HOC NEWS
Altai Capital nominates two directors for OraSure Technologies board By Investing.com - Investing.com Nigeria
Altai Capital nominates two directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Orasure Technologies confirms receipt of director nominations from Altai Capital - marketscreener.com
Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital - TradingView
OraSure (OSUR) Faces Board Nomination Challenge for 2026 - GuruFocus
0.58%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):